Finance

Lists
Q3 2026 earnings • released • EPS beat +82.14% • Revenue beat +102.93%
See results
XLO:NASDAQ
Xilio Therapeutics Inc
$8.47
-0.70%
(-0.060) 1D
Nov 11, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
$8.82
High
$8.85
Low
$8.40
Mkt. cap
55.73M
Avg. vol.
13.92K
Volume
3.53K
52-wk high
$11.30
52-wk low
$6.47
EPS
-$1.54
Beta
-0.11
Shares outstanding
6.58M
No. of employees
76
Open
$8.82
High
$8.85
Low
$8.40
Mkt. cap
55.73M
Avg. vol.
13.92K
Volume
3.53K
52-wk high
$11.30
52-wk low
$6.47
EPS
-$1.54
Beta
-0.11
Shares outstanding
6.58M
No. of employees
76
News stories
From web sources and news partners
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitexiliotx.com
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Buy
Maintained
-
-
11/13/2025
Last report
Nov 10, 2026
Fiscal period
Q3 2026
-$0.30 / -$1.68
+82.14%beat
Revenue / Est. (USD)
9.98M / 4.92M
+102.93%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.07M
13.69M
12.65M
18.69M
Cost of goods sold
14.32M
-37.92M
19.83M
14.56M
Cost of revenue
14.32M
-37.92M
19.83M
14.56M
Research and development expenses
-
56.04M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.67M
7.40M
6.93M
7.62M
Operating expense
6.67M
63.44M
6.93M
7.62M
Total operating expenses
21.00M
25.52M
26.76M
22.18M
Operating income
-1.93M
-11.84M
-14.11M
-3.49M
Other non operating income
-14.36M
24.70M
3.30M
-2.88M
EBT including unusual items
-16.29M
10.36M
-9.53M
-6.37M
EBT excluding unusual items
-16.29M
10.36M
-9.53M
-6.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.29M
10.36M
-9.53M
-6.37M
Net profit margin
-85.42%
75.70%
-75.34%
-34.09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.28M
-
Interest expense
-
-2.50M
-
-
Net interest expenses
-
-2.50M
1.28M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.59M
-11.51M
-13.77M
-3.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps